125 related articles for article (PubMed ID: 22369590)
1. Change in antimicrobial susceptibility of Escherichia coli urinary tract isolates at a single institution over a period of 10 years.
Walkty A; Lagacé-Wiens PR; Karlowsky JA; Hoban DJ; Manickam K; Adam H; Pieroni P; Alfa M
Can J Microbiol; 2012 Mar; 58(3):345-9. PubMed ID: 22369590
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.
Karlowsky JA; Lagacé-Wiens PRS; Adam HJ; Baxter MR; Laing NM; Walkty AJ; Zhanel GG
Int J Antimicrob Agents; 2019 Jul; 54(1):62-68. PubMed ID: 31034938
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
[TBL] [Abstract][Full Text] [Related]
5. [Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections].
Junquera S; Loza E; Baquero F
Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):197-201. PubMed ID: 15826543
[TBL] [Abstract][Full Text] [Related]
6. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
Karlowsky JA; Kelly LJ; Thornsberry C; Jones ME; Sahm DF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2540-5. PubMed ID: 12121930
[TBL] [Abstract][Full Text] [Related]
7. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
[TBL] [Abstract][Full Text] [Related]
8. Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples.
Erb S; Frei R; Tschudin Sutter S; Egli A; Dangel M; Bonkat G; Widmer AF
Swiss Med Wkly; 2018 Nov; 148():w14660. PubMed ID: 30440065
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study.
Alanazi MQ; Alqahtani FY; Aleanizy FS
Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):3. PubMed ID: 29422058
[TBL] [Abstract][Full Text] [Related]
12. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
Kahlmeter G; Poulsen HO
Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
[TBL] [Abstract][Full Text] [Related]
14. Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin.
O'Brien KA; Zhang J; Mauldin PD; Gomez J; Hurst JM; Sean Boger M; Bosso JA
Pharmacotherapy; 2015 May; 35(5):464-9. PubMed ID: 26011139
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
16. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
Zhanel GG; Karlowsky JA; Harding GK; Carrie A; Mazzulli T; Low DE; Hoban DJ
Antimicrob Agents Chemother; 2000 Apr; 44(4):1089-92. PubMed ID: 10722520
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
[TBL] [Abstract][Full Text] [Related]
19. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.
Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
